5VM
5AM Venture Management Portfolio holdings
AUM
$260M
This Quarter Return
-25.99%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$533M
AUM Growth
+$533M
(+8.2%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
30.8%
Top 10 Holdings %
Top 10 Hldgs %
89.07%
Holding
18
New
2
Increased
–
Reduced
5
Closed
1
Top Buys
| 1 |
PEAR
Pear Therapeutics, Inc. Class A Common Stock
PEAR
|
$116M |
| 2 |
Entrada Therapeutics
TRDA
|
$75.5M |
Top Sells
| 1 |
Crinetics Pharmaceuticals
CRNX
|
$14.2M |
| 2 |
Avidity Biosciences
RNA
|
$3.92M |
| 3 |
Vor Biopharma
VOR
|
$3.84M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$2.12M |
| 5 |
ARS Pharmaceuticals
SPRY
|
$1.69M |
Sector Composition
| 1 | Healthcare | 99.33% |
| 2 | Financials | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PEAR
1
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
| $116M | 21.68% |
+18,631,771
| New | +$116M |
|
|
2
Entrada Therapeutics
TRDA
$208M
| $75.5M | 14.17% |
+4,408,379
| New | +$75.5M |
|
|
3
Vor Biopharma
VOR
$250M
| $73.9M | 13.87% |
6,361,723
-330,706
| -5% | -$3.84M |
|
4
Rallybio
RLYB
$22.4M
| $40M | 7.5% |
4,190,724
| – | – |
|
|
AKUS
5
DELISTED
Akouos, Inc. Common Stock
AKUS
| $35.2M | 6.6% |
4,135,784
| – | – |
|
6
IDEAYA Biosciences
IDYA
$2.15B
| $33.1M | 6.2% |
1,398,066
| – | – |
|
7
Arvinas
ARVN
$568M
| $32.9M | 6.17% |
400,000
| – | – |
|
|
IMPL
8
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $24.9M | 4.67% |
2,884,791
| – | – |
|
|
9
Crinetics Pharmaceuticals
CRNX
$2.92B
| $24.5M | 4.6% |
862,286
-500,000
| -37% | -$14.2M |
|
10
scPharmaceuticals
SCPH
$295M
| $19.2M | 3.61% |
3,831,474
| – | – |
|
11
Q32 Bio
QTTB
$20.9M
| $16.5M | 3.1% |
4,535,919
| – | – |
|
|
ISEE
12
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $10.8M | 2.02% |
643,248
-126,752
| -16% | -$2.12M |
|
|
13
Avidity Biosciences
RNA
$5.99B
| $9.28M | 1.74% |
390,555
-165,000
| -30% | -$3.92M |
|
14
Janux Therapeutics
JANX
$1.37B
| $8.81M | 1.65% |
446,266
| – | – |
|
15
Cabaletta Bio
CABA
$133M
| $7.82M | 1.47% |
2,064,263
-295,000
| -13% | -$1.12M |
|
|
FVAM
16
DELISTED
5:01 Acquisition Corp. Class A Common Stock
FVAM
| $3.6M | 0.67% |
365,126
| – | – |
|
17
Cidara Therapeutics
CDTX
$1.66B
| $1.44M | 0.27% |
1,134,511
| – | – |
|
|
18
ARS Pharmaceuticals
SPRY
$1.15B
| – | – |
-169,748
| Closed | -$1.69M |
|